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Methods: Expression of RORalpha isoforms was analyzed by
semi-quantitative reverse transcriptase chain reaction (RT-PCR)
and immunocytochemistry. RORalpha1 overexpression and down-
expression were achieved by the transfections of expression vec-
tor and small interfering RNA (siRNA) of RORalpha1, respectively.
Their effects on the modulation of osteoblast metabolism markers
and tumor necrosis factor alpha (TNFalpha) induced inﬂamma-
tory response markers were determined by real-time RT-PCR,
western blot, enzyme-linked immunosorbent assay, gene reporter
luciferase assay and electrophoretic mobility shift assay.
Results: The overexpression of RORalpha1 increased alkaline
phosphatase (ALP), osteocalcin (OC) and collagen type I (COL
I) mRNA and activity or protein expression, while the silenc-
ing of RORalpha1 RNA inhibited these responses. In addition,
overexpression of RORalpha1 suppressed TNFα-induced produc-
tion of cyclooxygenase-2 (COX-2), prostaglandins E2 (PGE2) and
metalloproteinase-9 (MMP-9). Upon examination of signaling path-
ways, we found that RORalpha1 was able to block TNF alpha-
induced nuclear factor kappa B (NF-kB) activation.
Conclusions: RORalpha1 is involved in human osteoblast
metabolism by stimulating osteoblast marker expression and in-
hibiting inﬂammatory responses. These ﬁndings may encourage
further exploration of RORalpha1 as a potential target for the
treatment of bone disorders related to inﬂammation.
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A LOWER OSTEOPROTEGERIN/RANKL RATIO IS
ASSOCIATED WITH AN INCREASED SUBCHONDRAL BONE
REMODELING IN OSTEOARTHRITIS AGGRAVATED BY
PRIOR OSTEOPOROSIS IN RABBITS
M. Bellido1, L. Lugo1, S. Castañeda2, R. Largo1,
G. Herrero-Beaumont1
1Fundacion Jimenez Diaz, Madrid, Spain; 2Hosp. de la Princesa,
Madrid, Spain
Purpose: In previous studies, we have observed that prior sub-
chondral bone (SB) osteoporosis (OP) aggravated the cartilage
damage in a combined model of OP and osteoarthritis (OA) in
rabbits (Calvo et al. Osteoarthritis Cartilage 15:69-77, 2007). In
this work, our aim was to study whether an increased SB remod-
eling could account for the increased cartilage damage in rabbits
with OA aggravated by prior subchondral OP.
Methods: OP was induced in 20 (8 month-old; 3.5-4.8 kg body
weight), skeletally mature female NZ rabbits, by ovariectomy (OVX)
and intramuscular injections of methylprednisolone hemisuccinate
(1 mg/kg/day for 4 weeks; OP group). Ten age and gender-
matched additional animals were used as controls. Surgical OA
was simultaneously induced in the left knees of all the rabbits
through partial medial meniscectomy and anterior cruciate liga-
ment transection. The animals were sacriﬁced 22 weeks after
OVX. Then, left knees were considered as OA or as OA plus
OP (OPOA) and the right knees were used as OP or healthy
controls, respectively. The percentage of bone area/tissue area
(BAr/TAr) was assessed in the SB of the femurs after sacri-
ﬁce by micro- Computed Tomography. Osteoprotegerin (OPG),
RANKL and MMP-9 protein synthesis at the SB were evaluated
by western-blot studies. Nonpair-wise statistical comparisons were
done using Mann-Whitney test for the different variables studied
and correlations by Spearman’s test (SPSS vs. 15).
Results: At sacriﬁce, the BAr/TAr in the SB was signiﬁcantly di-
minished in OP, OA and OPOA knees when compared to healthy
knees (p<0.05), although a greater decrease was observed in the
OPOA knees (p<0.05 vs. OP and vs. OA). At SB, the OPG/RANKL
protein synthesis ratio was signiﬁcantly diminished in OA, OP
and OPOA knees when compared to healthy controls (Healthy:
1.36±0.14; OA: 1±0.02*; OP: 0.91±0.1*; OPOA: 0.7±0.04* ar-
bitrary units; *p<0.05 vs. healthy), although it was signiﬁcantly
lower in OPOA knees when compared to OP or to OA (p<0.05 for
both comparisons). MMP-9 protein synthesis in the SB was signif-
icantly increased both in OA and in OPOA knees in comparison
to healthy knees (Healthy: 100±7; OA: 362±90*; OP: 284±80;
OPOA: 690±180* arbitrary units; *p<0.05 vs. healthy). Further-
more, a signiﬁcantly greater increase was observed for OPOA
knees in comparison to OA knees. In addition, we observed a
positive correlation between BAr/TAr and OPG/RANKL ratio in the
SB of these rabbits (r=0.911; p=0.001).
Conclusions: The remodeling parameters BAr/TAr, OPG/RANKL,
both analyzed in the SB, were diminished in OA, OP and even
more in OPOA. In the same way, the MMP-9 synthesis was greater
in OPOA than in OA rabbits. Our results show that an increased
SB remodeling can be responsible for the severity of cartilage
damage in OA, at least in rabbits with prior OP. This ﬁnding can be
relevant since these pathologies are frequently found in the same
patients, in which OP can precede OA onset.
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OSTEOCLAST PHENOTYPE AND RESORPTIVE ACTIVITY
ARE MODIFIED DISTINCTLY BY DIFFERENT TYPES OF
OSTEOCLAST INHIBITORS - IMPLICATIONS FOR
OSTEOCLAST QUALITY?
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Purpose: Osteoarthritis (OA) is described as being a disorder that
has its origin in bone and cartilage. It is therefore interesting to
investigate the biological action of bone resorping cells also known
as the osteoclasts. Osteoclast inhibition can be used to investigate
the biological processes underlying bone remodeling; however the
direct effect on osteoclast phenotype caused by modulation of
both the organic and inorganic phase of bone during resorption
has not been investigated in detail. The aim of the current study
was to investigate the phenotype of resorptive human osteoclasts
after treatment with different types of inhibitors and thereby gain
more knowledge about bone turnover.
Methods: Mature human osteoclasts, generated from CD14+
monocytes, were seeded on bone slices and treated with inhibitors
of acidiﬁcation (baﬁlomycin; diphyllin; ethoxyzolamide), inhibitors
of proteolysis (E64 [cat. K inhibitor]; GM6001 [MMP inhibitor]) or a
bisphosphonate (Ibandronate). Bone resorption was measured by
Ca2+ (inorganic), CTX-I (organic), ICTP (organic, MMP generated)
and pit scoring. In addition, gelatinase activity and the osteoclast
marker TRACP were measured.
Results: All inhibitors of acidiﬁcation were equally potent with
respect to inhibition of organic and inorganic resorption, measured
both by resorption markers and pit scoring. Conversely, E64 ef-
fectively reduced organic resorption by 80%, whereas inorganic
resorption was modestly reduced. Resorbed bone area, ICTP
release and gelatinase activity were all increased for this treat-
ment. Treatment with GM6001 had no effect on neither organic
nor inorganic resorption alone; however, when combined with E64
degradation of the organic phase of bone was abrogated, whereas
inorganic resorption was reduced by 60%. Ibandronate completely
abrogated both organic and inorganic resorption, while TRACP
activity was strongly decreased.
Conclusions: Inhibitors of acidiﬁcation and Ibandronate potently
reduced both organic and inorganic resorption to the same level.
In face of that, inhibition of proteolysis leads to potent reduction
of organic resorption, but only modest reduction of inorganic
resorption, and even an increased resorbed bone area, possibly
due to MMP mediated compensation. These ﬁndings strongly
indicate that different anti-osteoclastic intervention strategies affect
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osteoclasts distinctly, resulting in separate osteoclast phenotypes.
Since bone formation is coupled to bone resorption, the multi-
layered osteoclast phenotype and quality may be related to bone
turnover and bone quality, which could prove important for the
pathogenesis of OA.
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HYALURONAN AND INTERMITTENT HYDROSTATIC
PRESSURE SYNERGISTICALLY SUPPRESSED MMP-13
AND IL-6 EXPRESSIONS IN OSTEOBLASTS FROM OA
SUBCHONDRAL BONE
N. Hiraoka, K.A. Takahashi, Y. Arai, K. Honjo, S. Nakagawa,
S. Tsuchida, K. Sakao, T. Kubo
Kyoto Prefectural Univ. of Med., kyoto, Japan
Purpose: Various inﬂammatory cytokines and proteases are in-
volved in the initiation and progression of osteoarthritis (OA).
We previously reported that the expressions of matrix metallo-
proteinase-13 (MMP-13) and interleukin-6 (IL-6) were augumented
in OA subchondral bone. The purpose of this study was to inves-
tigate the effects of hyaluronan (HA) and mechanical stress on
osteoblasts isolated from OA subchondral bone.
Methods: OA subchondral bone from the distal end of the femur
was harvested from 9 patients at total knee arthroplasty. The
subchondral bone underlying the degenerated articular cartilage
was cut into small pieces and incubated in DMEM for 3 weeks,
and then osteoblasts were isolated.
Subchondral bone osteoblasts (SBOs) were cultured with DMEM
conraining 30% ﬂuorescent labeled HA for 48 hours and washed
twice with PBS. The monolayer cultured cells were observed with
a ﬂuorescence microscope. As control, SBOs cultured without
ﬂuorescent labeled HA was used.
SBOs were divided into 4 experimental groups. Control group:
cultured without stimulation, HA group: incubated with HA (1000
mg/ml, 48 hours), IHP group: applied intermittent hydrostatic pres-
sure (IHP) (1/2 Hz, 5 MPa, 60 minutes), and HA+IHP group:
incubated with HA followed by IHP. Total RNA were extracted
and mRNA expression was examined by real-time RT-PCR for
MMP-13 and IL-6. In control group and HA+IHP group, culture
supernatant was harvested 24 hours after the application of HA
+ IHP, and concentrations of IL-6 and MMP-13 were measured
using an enzyme-linked immunosorbent assay (ELISA). Values
were analyzed statistically by Tukey-kramer’s test and paired t-test
and a p value less than 0.05 was considered signiﬁcant.
Results: In the ﬂuorescent labeled HA group, ﬂuorescence was
observed in the area of cytoplasm but not in nuclei 48 hours after
the administration.
The mRNA expressions of MMP-13 of the each group compared to
the control group were 101±18.2%, 89.3±14.1% and 51.2±7.5%
respectively, indicating that MMP-13 expression in the HA + IHP
group signiﬁcantly decreased compared to those in the control
group and in the HA group.
The IL-6 mRNA of the each group were 76.6±11.9 %, 73.2±10.5%
and 54.0±18.3%, indicating that IHP treatment and HA + IHP
treatment signiﬁcantly suppressed the IL-6 mRNA.The production
of MMP-13 and IL-6 were 51.3±11.6 (pg/ml) and 70.8±25.6 in
the control group. In the HA + IHP group, they were signiﬁcantly
reduced to 53.9±25.6 and 45.2±11.1.
Conclusions: The role of subchondral bone attracts attention
in the onset and/or progression of OA. It was reported that HA
inﬂuences metabolism in subchondral bone, and that subchon-
dral bone becomes more compliant and thereby reduces cartilage
stress. However, the mechanism of the inﬂuence of HA on sub-
chondral bone remains unclear. In this study, HA was exposed
to osteoblasts, and the enhanced expressions of MMP-13 and
IL-6 in OA osteoblasts were signiﬁcantly suppressed by HA in
combination with IHP. In the natural course of OA, a resorption of
subchondral bone was documented in the early stage of OA and
was considered to take an important role in the progression of
the disease. In OA, neovascularization between cartilage and sub-
chondral bone is observed while tidemark disappears. Therefore,
intra-articular injected HA could reach the subchondral tissue. The
results in this study suggest that intra-articular injection of HA
in combination with appropriate exercise could suppress MMP-13
and IL-6 expressions in subchondral bone, which may prevent
abnormal metabolism in osseous tissue in OA.
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INCREASE IN THE MEDIAL CORTICAL BONE THICKNESS
OF THE PROXIMAL TIBIA IS ASSOCIATED WITH THE
PROGRESSION OF RADIOGRAPHIC KNEE
OSTEOARTHRITIS (OA) IN RURAL JAPANESE POPULATION
- THE MATSUDAI KNEE OA SURVEY
T. Hayami1, Y. Koga2, G. Omori3, H. Watanabe4, H. Yamagiwa5
1Dept. of Orthopedic Surgery, Saiseikai Niigata Daini Hosp.,
Niigata, Japan; 2Dept. of Orthopedic Surgery, Niigata Kobari
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Transdisciplinary Res., Niigata Univ., Niigata, Japan; 4Dept. of
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Purpose: While increased subchondral bone thickness has been
well described in knee OA, changes in periarticular cortical bone
in OA patients have not been previously examined. The purpose
of this study is to investigate the association of cortical bone
thickness at proximal tibia in knee OA with varus deformity.
Methods: The Matsudai Knee OA Survey is a historical cohort
study, which was conducted to investigate the risk factors of
the disease in a rural Japanese population. We have conducted
an extensive the survey in Matsudai town Niigata city, Japan
since 1979. Matsudai knee OA survey was performed every 7
years. In this survey, check-up included an interview, physical
examination, anteroposterior standing radiographs of both knees.
OA was deﬁned as being present in a knee if radiographic grade of
2 or higher with Kellegren and Lawrence (KL) scale were detected.
Mal-alignment was determined according to the femoro-tibial angle
(FTA), and subjects were grouped into higher and lower FTA by
median FTA. In this study, we describe the cross-sectional data
collected from the 4th (2000) survey, which included 1260 people
(396 men and 527 women). Both medial and lateral cortical bone
thicknesses at proximal tibiae and femora were measured using
computer image analysis. Cortical bone thickness was compared
with KL grades, FTA groups (higher and lower groups divided
median FTA), BMI (4 groups of quartile).
Results: In female, both medial and lateral cortical bone thickness
of femur and lateral side of tibia decreased with age, but the medial
cortical thickness was not decrease with age. In male, only lateral
cortical thickness was decrease with age. Cortical bone thickness,
